Oral OKT3 for the Treatment of Active Ulcerative Colitis

Completed · Phase 1/Phase 2

Conditions studied: Ulcerative Colitis

In brief

This study will assess the safety and efficacy of orally delivered short-term OKT3 in participants with active ulcerative colitis.

Key facts

Study ID

NCT01287195

Run by

Brigham and Women's Hospital

People needed

6

Starts

2011-04-07

Expected to finish

2013-05-02

Last updated by the study team

2019-02-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.